about
Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.An approach to local immunotoxicity induced by adjuvanted vaccines.Systemic immunotoxicity reactions induced by adjuvanted vaccines.Sporothrix schenckii complex biology: environment and fungal pathogenicity.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.The Hen's Egg Test on Chorioallantoic Membrane: An Alternative Assay for the Assessment of the Irritating Effect of Vaccine Adjuvants.Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii.Response of Cytokines and Hydrogen Peroxide to Sporothrix schenckii Exoantigen in Systemic Experimental Infection.A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection.Involvement of major components from Sporothrix schenckii cell wall in the caspase-1 activation, nitric oxide and cytokines production during experimental sporotrichosis.Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.[Immunological adjuvants. Determinant factors in the efficacy-toxicity ratio of the contemporary vaccines].Repeated Exposition to Mercury (II) Chloride Enhances Susceptibility to S. schenckii sensu stricto Infection in Mice.Cell Wall Proteins-Stimulated BMDCs Are Able to Induce a Th1-Prone Cytokine Profile In VitroA Recombinant Enolase-Montanide™ PetGel A Vaccine Promotes a Protective Th1 Immune Response against a Highly Virulent by Toluene ExposureProgress in the Use of Antisense Oligonucleotides for Vaccine ImprovementImmunization with recombinant enolase of Sporothrix spp. (rSsEno) confers effective protection against sporotrichosis in miceProphylactic and therapeutic vaccines against sporotrichosis. Feasibility and prospectsSporothrix brasiliensis induces a more severe disease associated with sustained Th17 and regulatory T cells responses than Sporothrix schenckii sensu stricto in mice
P50
Q37353525-1E388192-A7C3-4A39-B35E-ED234EAA7DE4Q37371036-60407702-593F-4C0F-B8F1-918A972655CAQ38130785-2D4E77ED-FB6B-4CC1-9498-962C0A78F308Q38194335-A0EA52E2-CE40-41DC-8C82-2EE5873D71A5Q38241155-499F3CB2-E208-4410-A147-EFD49E4A5F11Q38264288-389B9DD2-A806-4F06-9532-E8A33A032729Q39298187-240EFF9C-2134-490B-91F2-07FA8256B1E6Q40536878-458EB260-14DC-4981-B84E-E271C301C874Q40896802-70E22237-B75B-40FB-89BB-F7A48408C571Q40918762-10BCAA42-B84C-42C3-91F7-8392CB907CAEQ41428176-9F38BBA7-3194-4BBA-A94F-0B4E6948DDCFQ41745750-342B6AEB-5EAD-4148-A5CA-3569B56CAC23Q45374428-63BA2835-7000-474A-99C9-A0223D3E7C9EQ46438917-7305AF50-D26E-40FB-B26C-196C3A1C01A3Q55417442-78E3939E-B079-4C7A-AAC6-5B43524A524BQ58769947-916CE379-0A4C-471C-81E2-1A2DBDE1F952Q64056348-661DCCCF-264C-4CA7-9925-A1E1A994AAF1Q89805468-9DB0337D-9DA1-4198-AE27-2B39E4616847Q91361918-95ACBD18-26A9-44A5-ABBC-89455A47C9FCQ92765491-9356061B-1B0D-41BB-87F0-01986F9A2869Q93198545-DE84B45E-01F3-4289-98C9-7A870BEB67D7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A Batista-Duharte
@en
A Batista-Duharte
@nl
type
label
A Batista-Duharte
@en
A Batista-Duharte
@nl
prefLabel
A Batista-Duharte
@en
A Batista-Duharte
@nl
P31
P496
0000-0002-1875-0518